You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
|
|---|---|
| Published in |
New England Journal of Medicine, February 2013
|
| DOI | 10.1056/nejmoa1111096 |
| Pubmed ID | |
| Authors |
Alexander T Cohen, Theodore E Spiro, Harry R Büller, Lloyd Haskell, Dayi Hu, Russell Hull, Alexandre Mebazaa, Geno Merli, Sebastian Schellong, Alex C Spyropoulos, Victor Tapson |
| Abstract |
The clinically appropriate duration of thromboprophylaxis in hospitalized patients with acute medical illnesses is unknown. In this multicenter, randomized, double-blind trial, we evaluated the efficacy and safety of oral rivaroxaban administered for an extended period, as compared with subcutaneous enoxaparin administered for a standard period, followed by placebo. |
X Demographics
The data shown below were collected from the profiles of 99 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 19 | 19% |
| United States | 14 | 14% |
| United Kingdom | 5 | 5% |
| Mexico | 3 | 3% |
| Canada | 2 | 2% |
| Switzerland | 1 | 1% |
| France | 1 | 1% |
| Ecuador | 1 | 1% |
| Poland | 1 | 1% |
| Other | 11 | 11% |
| Unknown | 41 | 41% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 73 | 74% |
| Practitioners (doctors, other healthcare professionals) | 19 | 19% |
| Scientists | 4 | 4% |
| Science communicators (journalists, bloggers, editors) | 3 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 485 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 4 | <1% |
| Denmark | 3 | <1% |
| United States | 3 | <1% |
| Spain | 3 | <1% |
| Netherlands | 2 | <1% |
| Colombia | 2 | <1% |
| Canada | 2 | <1% |
| United Kingdom | 2 | <1% |
| Chile | 1 | <1% |
| Other | 6 | 1% |
| Unknown | 457 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 84 | 17% |
| Researcher | 68 | 14% |
| Student > Postgraduate | 51 | 11% |
| Student > Master | 38 | 8% |
| Student > Bachelor | 37 | 8% |
| Other | 133 | 27% |
| Unknown | 74 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 302 | 62% |
| Pharmacology, Toxicology and Pharmaceutical Science | 45 | 9% |
| Agricultural and Biological Sciences | 13 | 3% |
| Biochemistry, Genetics and Molecular Biology | 8 | 2% |
| Nursing and Health Professions | 4 | <1% |
| Other | 21 | 4% |
| Unknown | 92 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 519. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2023.
All research outputs
#49,406
of 26,017,215 outputs
Outputs from New England Journal of Medicine
#1,656
of 32,765 outputs
Outputs of similar age
#252
of 297,148 outputs
Outputs of similar age from New England Journal of Medicine
#15
of 302 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,765 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.4. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 297,148 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 302 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.